Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Antitrust Lawsuit Brought Against Drug Manufacturer Based on Its Allegedly Improper Listing of Device Patents in the FDA’s Orange Book https://t.co/jD1oGioAQm
Federal Circuit Holds Post-Invention Funding Agreement Subject to Government Licensing Provision of Bayh-Dole Act https://t.co/ZpxRDfFpLi | by @akin_gump
A US appeals court sent a West Virginia city and county's bid to revive their $2.5 billion lawsuit against top drug distributors over the opioid crisis to the state's highest court https://t.co/irGny8phGr https://t.co/uSDOLIxvZq
A federal appeals court decision could prompt states to challenge drugmaker restrictions on discounts. The court revived an antitrust lawsuit by Regeneron Pharmaceuticals against Novartis over prescription treatments for eye disorders. Additionally, the court sent a $2.5 billion lawsuit against drug distributors over the opioid crisis to West Virginia's highest court.